TOT BIOPHARM International Company Limited (1875.HK)

HKD 1.65

(0.0%)

Total Debt Summary of TOT BIOPHARM International Company Limited

  • TOT BIOPHARM International Company Limited's latest annual total debt in 2023 was 345.65 Million CNY , up 19.38% from previous year.
  • TOT BIOPHARM International Company Limited's latest quarterly total debt in 2024 Q2 was 383 Million CNY , down 0.0% from previous quarter.
  • TOT BIOPHARM International Company Limited reported annual total debt of 289.52 Million CNY in 2022, up 38.82% from previous year.
  • TOT BIOPHARM International Company Limited reported annual total debt of 208.56 Million CNY in 2021, up 2716.16% from previous year.
  • TOT BIOPHARM International Company Limited reported quarterly total debt of 356.32 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • TOT BIOPHARM International Company Limited reported quarterly total debt of 345.65 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Total Debt of TOT BIOPHARM International Company Limited (2023 - 2017)

Year Total Debt Total Debt Growth
2023 345.65 Million CNY 19.38%
2022 289.52 Million CNY 38.82%
2021 208.56 Million CNY 2716.16%
2020 7.4 Million CNY -90.14%
2019 75.07 Million CNY 380.41%
2018 15.62 Million CNY -94.19%
2017 268.78 Million CNY 0.0%

Peer Total Debt Comparison of TOT BIOPHARM International Company Limited

Name Total Debt Total Debt Difference
Uni-Bio Science Group Limited 52.86 Million HKD -553.812%
CK Life Sciences Int'l., (Holdings) Inc. 5.93 Billion HKD 94.172%